<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03396159</url>
  </required_header>
  <id_info>
    <org_study_id>N-6-2018</org_study_id>
    <nct_id>NCT03396159</nct_id>
  </id_info>
  <brief_title>Validity of Mini Fluid Challenge Post Liver Transplantation</brief_title>
  <official_title>Validity of Mini Fluid Challenge to Assess Fluid Responsiveness Post Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      our study aim to assess the validity of using mini fluid challenge to assess the volaemic
      status of patients after liver transplantation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After approval of institutional ethical committee and after informed patient consent,
      patients fulfilling criteria will be involved. Upon ICU admission, patients will be connected
      to full monitoring and confirming patient hemodynamic stability and no active bleeding
      through drains. Patients will be in supine position and baseline readings will be recorded.
      Fluid responsiveness will be assessed with mini fluid challenge by 150 ml of albumin 5% given
      over 1 minute. After fluid administration stroke volume (SV) assessed by trans thoracic echo
      (TTE) and other hemodynamic parameters will be recorded. Remaining 350 ml of albumin 5% will
      be continued over 14 minute to have total volume given 500 ml. after fluid administration SV
      and other parameters will be recorded. The fluid challenge will be given intravenously via a
      specific wide pore venous line. Fluid responsiveness will be defined as an increase in the SV
      by 15% after the infusion of fluid.

      TT Echo Examination:

      A single LVOT diameter will be measured for each patient as the distance between the
      inﬂection points at the base of the aortic valve cusps from the left parasternal long axis
      view during systole.

      Assuming a circular cross section, the LVOT area will be calculated from the LVOT diameter
      as:

      π X (LVOT diameter/ 2)2 = (LVOT diameter)2 X 0.785 Pulse wave Doppler sampling cursor will be
      placed in the middle of the LVOT immediately proximal to the aortic valve in 5 chamber apical
      view.

      The sonographer manually will trace the velocity-time envelope (VTI). SV values will be
      calculated by multiplying VTI by cross sectional area.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>stroke volume</measure>
    <time_frame>1 minute after mini fluid administration</time_frame>
    <description>assessed by trans thoracic echo</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>baseline 10 minutes after intensive care admission, 1 minute after mini fluid challenge and 1 minute after 500 ml of fluid administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke volume</measure>
    <time_frame>baseline 10 minutes after intensive care admission and 1 minute after 500 ml of fluid administration</time_frame>
    <description>assessed by trans thoracic echo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean arterial blood pressure</measure>
    <time_frame>baseline 10 minutes after intensive care admission and 1 minute after 500 ml of fluid administration</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>mini fluid challenge</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mini fluid will be given and stroke volume will be assessed before and after</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>mini fluid challenge</intervention_name>
    <description>mini fluid challenge will be given to diagnose if patient is need fluid resuscitation or not</description>
    <arm_group_label>mini fluid challenge</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients post liver transplantation.

          -  ASA III- IV

          -  Age &gt; 18 years

        Exclusion Criteria:

          -  Age less than 18 years.

          -  Patient with fulminant liver failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ahmed mohamed mokhtar, M.D</last_name>
    <role>Study Director</role>
    <affiliation>kasralainy faculty of medicine, Cairo university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed Elayashy Mohamed Ahmed Hassan, M.D</last_name>
    <phone>00201001833155</phone>
    <email>mohamedelayashy@kasralainy.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>amr hussien sayed, M.D</last_name>
    <phone>00201223657694</phone>
    <email>AmrHussein1981@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kasr Alainy Hospital , Faculty of Medicine</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mohamed elayashy mohamed ahmed hassan, M.D</last_name>
      <phone>00201001833155</phone>
      <email>mohamedelayashy@kasralainy.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Bechstein WO, Neuhaus P. [Bleeding problems in liver surgery and liver transplantation]. Chirurg. 2000 Apr;71(4):363-8. Review. German.</citation>
    <PMID>10840602</PMID>
  </reference>
  <reference>
    <citation>Leavy JA, Weil MH, Rackow EC. 'Lactate washout' following circulatory arrest. JAMA. 1988 Aug 5;260(5):662-4.</citation>
    <PMID>3392792</PMID>
  </reference>
  <reference>
    <citation>Kiszka-Kanowitz M, Henriksen JH, Møller S, Bendtsen F. Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. J Hepatol. 2001 Nov;35(5):605-12.</citation>
    <PMID>11690706</PMID>
  </reference>
  <reference>
    <citation>Henriksen JH. Volume adaptation in chronic liver disease: on the static and dynamic location of water, salt, protein and red cells in cirrhosis. Scand J Clin Lab Invest. 2004;64(6):523-33. Review.</citation>
    <PMID>15370457</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 25, 2017</study_first_submitted>
  <study_first_submitted_qc>January 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2018</study_first_posted>
  <last_update_submitted>February 19, 2018</last_update_submitted>
  <last_update_submitted_qc>February 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Mohamed Elayashy Mohamed Ahmed Hassan</investigator_full_name>
    <investigator_title>lecturer of anesthesia</investigator_title>
  </responsible_party>
  <keyword>liver transplantation</keyword>
  <keyword>mini fluid challenge</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

